Credit Suisse Ag Infla Rx N.V. Transaction History

Credit Suisse Ag

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$4.59 - $8.96 $47,942 - $93,587	-10,445 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$2.65 - $6.08 $27,679 - $63,505	10,445 New	10,445 $40,000
Q3 2019 Nov 12, 2019	SELL	$2.47 - $3.51 $99,570 - $141,495	-40,312 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$3.06 - $51.61 $123,354 - $2.08 Million	40,312 New	40,312 $128,000

12.9M

19.3K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $112M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.